News
Roche’s Flatiron Health is celebrating a milestone. Over the last year, the company has tripled the size of its international ...
USA News Group News Commentary – Cancer diagnoses are climbing fastest among younger women, sparking alarm that looming cuts ...
11h
Doncaster Free Press on MSNDoncaster pageant queen to take on 125ft charity abseil for Cancer Research UK
Charlotte Lister, the reigning Ms Eco Pageants UK, is preparing to take on a 125-foot abseil from the roof of the prestigious Francis Crick Institute in London this September in aid of Cancer Research ...
The cancer pain market, valued at USD 6.53 billion in 2024, is projected to reach USD 11.81 billion by 2034, with a CAGR of 6 ...
CRBN/VHL, Targeted Glue™ degraders for oncology and immunology indications Cambridge, UK, 16 July 2025 – Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery of ...
(nee Sargent) Of Mareham-le-Fen passed away peacefully, on 23rd June 2025 aged 79 years. Funeral service to be held at Boston ...
For only the second time in almost a quarter of a century, Cancer Research UK is seeking a new headline partner for its Race ...
15d
Peterborough Telegraph on MSNCancer Research UK funds ground-breaking study in Cambridge set to transform cervical screening
Cancer Research UK has awarded £457,000 to support a pioneering study in Cambridge that could play a pivotal role in the prevention and early detection of cervical cancer.
Breakthrough cancer test predicts whether chemotherapy will work Test, developed by University of Cambridge, looks at structure of tumour DNA and forecasts whether it will resist treatment ...
Dr Iain Foulkes, director at Cancer Research UK, which funded the research, said: “The days of chemotherapy being offered as a ‘one-size-fits-all’ treatment are ending.
New research has revealed rising rates of early onset bowel cancer among young adults - especially in women. The Mirror spoke to Cancer Research UK about tackling this 'global phenomenon' ...
New leukaemia treatment hailed as 'milestone' in cancer management The Flair trial saw two targeted cancer drugs perform better than standard chemotherapy, halting disease progression in 94% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results